|
J. Biol. Chem., Vol. 278, Issue 18, 15484-15494, May 2, 2003
Biochemical Characterization of Proline Racemases from the Human
Protozoan Parasite Trypanosoma cruzi and Definition of
Putative Protein Signatures*
Nathalie
Chamond §,
Christophe
Grégoire §¶,
Nicolas
Coatnoan ,
Catherine
Rougeot ,
Lucio Holanda
Freitas-Junior ,
José Franco
da Silveira**,
Wim M.
Degrave , and
Paola
Minoprio §§
From the Departments of Immunology and
Parasitology, Institut Pasteur, Paris, 75724, France,
** Department of Microbiology, Immunology and Parasitology,
Unifesp/Escola Paulista de Medicina, Sao Paulo
04023-062, Brazil, and  Department of
Biochemistry and Molecular Biology, Instituto Oswaldo Cruz, Rio
de Janeiro 21045-900, Brazil
Received for publication, October 23, 2002, and in revised form, January 30, 2003
 |
ABSTRACT |
Proline racemase catalyzes the
interconversion of L- and
D-proline enantiomers and has to date been described in
only two species. Originally found in the bacterium Clostridium
sticklandii, it contains cysteine residues in the active site and
does not require co-factors or other known coenzymes. We recently
described the first eukaryotic amino acid (proline) racemase, after
isolation and cloning of a gene from the pathogenic human parasite
Trypanosoma cruzi. Although this enzyme is intracellularly
located in replicative non-infective forms of T. cruzi,
membrane-bound and secreted forms of the enzyme are present upon
differentiation of the parasite into non-dividing infective forms. The
secreted form of proline racemase is a potent host B-cell mitogen
supporting parasite evasion of specific immune responses. Here we
describe that the TcPRAC genes in T. cruzi encode functional intracellular or secreted versions of
the enzyme exhibiting distinct kinetic properties that may be relevant
for their relative catalytic efficiency. Although the
Km of the enzyme isoforms were of a similar order
of magnitude (29-75 mM), Vmax
varied between 2 × 10 4 and 5.3 × 10 5 mol of L-proline/s/0.125 µM
of homodimeric recombinant protein. Studies with the enzyme-specific
inhibitor and abrogation of enzymatic activity by site-directed
mutagenesis of the active site Cys330 residue reinforced
the potential of proline racemase as a critical target for drug
development against Chagas' disease. Finally, we propose a protein
signature for proline racemases and suggest that the enzyme is present
in several other pathogenic and non-pathogenic bacterial genomes of
medical and agricultural interest, yet absent in mammalian host,
suggesting that inhibition of proline racemases may have therapeutic potential.
 |
INTRODUCTION |
D-Amino acids have long been described in the cell
wall of Gram-positive and especially Gram-negative bacteria, where they constitute essential elements of the peptidoglycan and as substitutes of cell wall techoic acids (1). Moreover, various types of D-amino acids were discovered in a number of small peptides
made by a variety of microorganisms through non-ribosomal protein
synthesis (2) that function mainly as antibiotic agents. However, these examples were considered exceptions to the rule of homochirality, and a
dogma persisted that only L-amino acid enantiomers were present in eukaryotes, apart from a very low level of
D-amino acids from spontaneous racemization because of
aging (3). Recently, an increasing number of studies have reported the
presence of various D-amino acids either as
protein-bound (4) or under free forms (5) in a wide variety of
organisms, including mammals. The origin of free D-amino
acids is less clear than that of protein bound D-amino
acids. For instance, in mammals, free D-amino acids may
originate from exogenous sources (as described in Ref. 6), but the
recent discovery of amino acid racemases in eukaryotes has also
uncovered an endogenous production of D-amino acids, questioning their specific functions. Thus, the level of
D-aspartate is developmentally regulated in rat embryos
(7); the binding of D-serine to
N-methyl-D-aspartate mouse brain
receptors promotes neuromodulation (8, 9) and D-aspartate
appears to be involved in hormonal regulation in endocrine tissues
(10). All amino acid racemases require pyridoxal phosphate as a
co-factor except proline and hydroxyproline racemases, which are
co-factor-independent enzymes. Two reports have been published
addressing the biochemical and enzymatic characteristics of
the proline racemase from the Gram-positive bacterium
Clostridium sticklandii (11, 12). A reaction
mechanism was proposed whereby the active site Cys256 forms
a half-reaction site with the corresponding cysteine of the other
monomer in the active, homodimeric enzyme.
Although a variety of racemases and epimerases has been
demonstrated in bacteria and fungi, we recently described the first eukaryotic amino acid (proline) racemase isolated from the infective metacyclic forms of the parasitic protozoan Trypanosoma
cruzi, the causative agent of Chagas' disease in humans (13).
This parasite-secreted proline racemase (TcPRAC) was shown
to be a potent mitogen for host B cells and plays an important role in T. cruzi immune evasion and persistence through polyclonal
lymphocyte activation (13). This protein, previously annotated as
TcPA45, with monomer size of 45 kDa, is only expressed and released by infective metacyclic forms of the parasite. The genomic organization and transcription of TcPRAC proline racemase gene indicated
the presence of two homologous genes per haploid genome
(TcPRACA and TcPRACB). Furthermore, localization
studies using specific antibodies directed to 45-kDa TcPRAC
protein revealed that an intracellular and/or membrane-associated
isoform, with monomer size of 39 kDa, is expressed in non-infective
epimastigote forms of the parasite. Computer-assisted analysis of the
TcPRACA gene sequence suggested that it could give
rise to both isoforms (45 and 39 kDa) of parasite proline racemases
through a mechanism of alternative trans-splicing, one of
which would contain a signal peptide (13). In addition, preliminary
analysis of putative TcPRACB gene sequences had revealed several differences that include point mutations as compared with TcPRACA but that also suggest that TcPRACB gene
could only encode an intracellular isoform of the enzyme as the gene
lacks the export signal sequence. Any of these molecular mechanisms
per se would ensure the differential expression of
intracellular and extracellular isoforms of proline racemases produced
in different T. cruzi developmental stages.
Primarily it was essential to elucidate whether TcPRACB gene
could encode a functional proline racemase. To answer this question we
have expressed TcPRACA and TcPRACB paralogue
genes in Escherichia coli and performed detailed studies on
biochemical and enzymatic characteristics of the recombinant proteins.
We show here that TcPRACB indeed encodes a functional
proline racemase that exhibits slightly different kinetic parameters
and biochemical characteristics when compared with TcPRACA
enzyme. Enzymatic activities of the respective recombinant proteins
showed that the 39-kDa intracellular isoform of proline racemase
produced by TcPRACB construct is more stable and has a
higher rate of D-/L-proline interconversion
than the 45-kDa isoform produced by TcPRACA. Additionally,
the dissociation constant of the enzyme-inhibitor complex
(Ki) obtained with pyrrole-2-carboxylic acid, the
specific inhibitor of proline racemases, is lower for the recombinant
TcPRACB enzyme. Moreover, we show that Cys330 is
a key amino acid of the proline racemase active site, because the
activity of the enzyme is totally abolished by site-directed mutagenesis of this residue. Finally, multiple alignment of proline racemase amino acid sequences allowed the definition of protein signatures that can be used to identify putative proline racemases in
other microorganisms. The significance of the presence of proline racemase in eukaryotes, particularly in T. cruzi, is
discussed, as well as the putative consequences of this enzymatic
activity in the biology and infectivity of the parasite.
 |
EXPERIMENTAL PROCEDURES |
Cloning and Automated Sequencing--
phage and
plasmid DNA were prepared using standard techniques, and direct
sequencing was accomplished with the Big dye Terminator kit
(PerkinElmer Life Sciences) according to the manufacturer's instructions. Extension products were run for 7 h in an ABI 377 automated sequencer. Briefly, to obtain the full length of the TcPRAC gene, 32P-labeled 239-bp PCR product was
used as a probe to screen a T. cruzi clone CL Brener
Fix II genomic library (see details in Ref. 13). We isolated four
independent positive phages. Restriction analysis and Southern blot
hybridization showed two types of genomic fragments, each represented
by two phages. Complete sequence and flanking regions of representative
phages for each pattern was done. Complete characterization of
TcPRACA gene, representing the first phage type,
was described previously in Ref. 13. Full sequence of the putative
TcPRACB gene, representing the second phage type, was then
performed, and primers internal to the sequence were used for
sequencing as described before (13).
Chromoblots--
Epimastigote forms of T. cruzi
(clone CL Brener) are maintained by weekly passage in LIT medium.
Agarose (0.7%) blocks containing 1 × 107 cultured
parasites were lysed with 0.5 M EDTA/10 mM
Tris/1% sarcosyl, pH 8.0, digested by proteinase K and washed in 10 mM Tris/1 mM EDTA, pH 8.0. Pulsed field gel
electrophoresis was carried out at 18 °C using the Gene Navigator
apparatus (Amersham Biosciences) in 0.5× TBE. Electrophoresis were
performed as described (14). Gels were then stained with ethidium
bromide, photographed, exposed to UV light (265 nm) for 5 min, and
further blotted under alkaline conditions to a nylon filter
(HybondN+; Amersham Biosciences). DNA probe, obtained by
PCR amplification of TcPRACA gene with Hi-45 (5' CTC TCC CAT
GGG GCA GGA AAA GCT TCT G 3') and Bg-45 (5' CTG AGC TCG ACC AGA T(CA)T
ACT GC 3') oligonucleotides (as described in Ref. 13), was labeled with dATP32 using a Megaprime DNA labeling system (Amersham
Biosciences). The chromoblot was hybridized overnight in 2×
Denhardt's/5× saline/sodium phosphate/EDTA/1.5% SDS at 55 °C and
washed in 2× saline/sodium phosphate/EDTA/0.1% SDS followed by 1×
saline/sodium phosphate/EDTA at 60 °C. Autoradiography was obtained
by overnight exposure of the chromoblot using a PhosphorImager
cassette (Molecular Dynamics).
Plasmid Construction and Protein
Purification--
TcPRACA gene fragment starting at codon
30 was obtained by PCR, using Hi- and Bg-45 primers, and cloned in
frame with a C-terminal His6 tag into the pET28b(+)
expression vector (Novagen-Tebu, Le Perray en Yvelines, France). The
fragment encoding for the TcPRACB consisted of a
HindIII digestion of TcPRACB gene fragment
obtained by similar PCR and cloned in-frame with a C-terminal
His6 tag into the pET28b(+) expression vector. Respective
recombinant proteins TcPRACA and TcPRACB were
produced in E. coli BL21 (DE3) (Invitrogen) and purified
using immobilized metal affinity chromatography on nickel columns
(Novagen-Tebu, Le Parray en Yvelines, France) following the
manufacturer's instructions.
Size Exclusion Chromatography--
rTcPRACA and
rTcPRACB proteins were purified as described above and
dialyzed against phosphate-buffered saline, pH 7.4, or 0.2 M NaOAc, pH 6.0, elution buffers in dialysis cassettes
(Slide-A-lyzer 7K; Pierce), overnight at 4 °C. The final protein
concentration was adjusted to 2 mg/ml, and 0.5 ml of the solution were
loaded onto Amersham Biosciences Superdex 75 column (HR10 × 30),
calibrated previously with a medium range protein calibration kit
(Amersham Biosciences). Size exclusion chromatography was carried out
using a fast protein liquid chromatography system (AKTA Purifier;
Amersham Biosciences). Elution was performed at a constant flow rate of 0.5 ml/min, protein fractions of 0.5 ml were collected, and the absorbance was monitored at 280 nm. Each fraction was assayed in
racemization assays as described below. Fractions B1 and B5 were
reloaded in the Superdex 75 column and submitted to a further size
exclusion chromatography to verify the purity of the fractions.
Racemization Assays--
The percent of racemization with
different concentrations of L-proline,
D-proline, L-hydroxy (OH)-proline,
D-hydroxy (OH)-proline was calculated as described (13) by
incubating a 500-µl mixture of 0.25 µM dimeric protein
and 40 mM substrate in 0.2 M sodium acetate, pH
6.0, for 30 min or 1 h at 37 °C. The reaction was stopped by
incubating for 10 min at 80 °C and freezing. Water (1 ml) was then
added, and the optical rotation was measured in a polarimeter 241MC
(PerkinElmer Life Sciences) at a wavelength of 365 nm, in a cell with a
path length of 10 cm, at a precision of 0.001 °. The percent of
racemization of 40 mM L-proline as a function
of pH was determined using 0.2 M sodium acetate, potassium phosphate, and Tris-HCl buffers; reactions were incubated 30 min at
37 °C as described above. All reagents were purchased from Sigma.
Kinetic Assays--
Concentrations of L- and
D-proline were determined polarimetrically from the optical
rotation of the solution at 365 nm in a cell of 10-cm path length,
thermostated at 37 °C. Preliminary assays were done with 40 mM L-proline in 0.2 M sodium
acetate, pH 6, in a final volume of 1.5 ml. Optical rotation was
measured every 5 s during 10 min and every 5 min to 1 h.
After determination of the linear part of the curve, velocity in 5-160
mM substrate was measured every 30 s during 10 min to
determine Km and Vmax.
Calculations were done using the Kaleïdagraph program. Inhibition assays were done by incubating 0.125 µM
dimeric protein, 6.7 µM-6 mM
pyrrole-2-carboxylic acid
(PAC),1 20 to 160 mM L-proline, as described above. Graphic
representation and linear curve regression allowed the determination of
Ki as [PAC]/[(slope with PAC/slope without
PAC) 1]. All reagents were purchased from Sigma.
Site-directed Mutagenesis of
C330STcPRACA--
Site-directed mutagenesis was performed
by PCR, adapting the method of Higuchi et al. (15). Briefly,
mutation of Cys330 of the proline racemase active site was
produced by two successive polymerase chain reactions based on
site-directed mutagenesis using two overlapping mutagenic primers,
act-1 (5' GCG GAT CGC TCT CCA AGC GGG ACA GGC
ACC 3') and act-2 (5' GGT GCC TGT CCC GCT TGG
AGA GCG ATC CGC 3'), designed to introduce a single codon mutation in
the active site by replacement of the cysteine (TGT) at position 330 by
a serine (AGC). A first step standard PCR amplification was performed
using the TcPRACA DNA as template and a mixture of act-1
primer and the reverse C terminus primer, Bg-45 (5' CTG AGC TCG ACC AGA
T(C/A)T ACT GC 3') (codon 423) or a mixture of act-2 primer and the
forward N terminus primer, Hi-45 (5' CTC TCC CAT GGG GCA GGA AAA GCT
TCT G 3') (codon 53) (see Fig. 5). Resulting amplified fragments of
316 and 918 bp, respectively, were purified by a Qiagen PCR extraction
kit as prescribed and further ligated by T4 ligase to generate a
template consisting of the full-length of a potentially mutated
TcPRACA* coding sequence used for the second step PCR.
Amplification of this template was performed using forward Hi-45 and
reverse Bg-45 primers, and the resulting TcPRACA* fragment
encoding for the mature proline racemase was purified and cloned in
pCR®2.1-TOPO® vector (Invitrogen). TOP10
competent E. coli were transformed with the
pCR®2.1-TOPO®-TcPRACA* construct
and plasmid DNA isolated from individual clones prepared for DNA
sequencing. Positive mutants were then subcloned in-frame with a
C-terminal His6 tag into the
NcoI/SacI sites of the pET 28b(+) expression
vector (Novagen-Tebu, Le Parray en Yvelines, France). Subclones of
pET28b(+)-TcPRACA* produced in E. coli (DH5 ) were sequenced again to confirm the presence of the mutation (not shown). Soluble recombinant C330STcPRACA protein
was produced in E. coli BL21(DE3) (Invitrogen) and purified
using a nickel column (Novagen-Tebu), according the manufacturer's instructions.
 |
RESULTS |
Expression of a Functional Intracellular Isoform of Proline
Racemase--
We have previously characterized (13) a
TcPRAC gene from T. cruzi and demonstrated
in vivo and in vitro that it encodes a proline
racemase enzyme. Analysis of the genomic organization and transcription
of the TcPRAC gene indicated the presence of two paralogue
gene copies per haploid genome, named TcPRACA
(GenBankTM accession number AF195522) and
TcPRACB (GenBankTM accession number
AY140947). We showed that TcPRACA encodes a
functional co-factor-independent proline racemase, closely resembling the C. sticklandii proline racemase (CsPR) (GenBankTM
accession number E101199) (11). We now sequenced the full-length of
TcPRACB, and, as can be observed in Fig.
1A, TcPRACA and
TcPRACB genes both possess the characteristic trypanosome
polypyrimidine-rich motifs in the intergenic region that are crucial
trans-splicing signals when located upstream of an
(AG)-dinucleotide used as acceptor site. As in other T. cruzi genes, UUA triplets are found at the end of the 3'
untranslated region preceding the polyadenylation site. Comparison
between the two sequences revealed 14 point mutations (resulting in
96% identity) giving rise to seven amino acid differences. When
expressed, the TcPRACB is predicted to produce a shorter protein (39 kDa) whose translation would start at the ATG codon at
position 274 located downstream of the (AG)-spliced leader acceptor
site (at position 175). In comparison, TcPRACA has an open
reading frame that encodes a peptide with an apparent molecular mass of
45 kDa. The schematic protein sequence alignment of the two proteins
TcPRACA and TcPRACB depicted in Fig.
1B reveals that TcPRACB proline racemase lacks
the amino acid sequence corresponding to the signal peptide observed in
the TcPRACA protein (hatched box in the figure;
see predicted cleavage site in Fig. 1C). Therefore the
TcPRACB would produce a 39-kDa, intracellular, and
non-secreted isoform of the protein. As with CsPR (11) and
TcPRACA (13) (Fig. 1B), the active site of
proline racemase is conserved in TcPRACB sequence.
Furthermore, while differing by only seven amino acids, both the
TcPRACA and TcPRACB sequences display around 50% homology to the CsPR (13). In accordance with other protein-coding genes in T. cruzi, TcPRAC genes are located on
two different chromosomal bands of which one contains three or more
chromosomes of similar size; see Fig. 1D. Thus,
hybridization of blots containing T. cruzi CL Brener
chromosomal bands separated by pulsed field gel electrophoresis
revealed that sequences recognized by an homologous probe to both
TcPRACA and TcPRACB are mapped in neighboring
migrating bands of ~0.9 and 0.8 Mb, corresponding to regions
VII and V, respectively, according to the numbering system of Cano
et al. (14).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
Comparative analysis of sequences of T. cruzi TcPRACA and TcPRACB proline racemase
isoforms. A, alignment of TcPRACA
(Tc-A) and TcPRACB (Tc-B) nucleotide
sequences. Non-coding sequences are shown in italics;
trans-splicing signals are underlined; putative spliced
leader acceptor sites are double underlined; the region
encoding the computer-predicted signal peptide is indicated by a
double-headed arrow; initiation of translation for TcPRACA and
TcPRACB are shown by single-headed arrows;
nucleotides are shaded in light and dark gray and
represent silent mutations or point mutations, respectively; the
proline racemase active site is in a box; UUA triplets are
underlined in bold and precede polyadenylation sites that
are double-underlined. B, schematic
representation of amino acid sequence alignments of T. cruzi
TcPRACA (Tc-A) and TcPRACB (Tc-B)
proline racemases. The common scale is in amino acid residue positions
along the linear alignment. and represent the initiation codons
for TcPRACA and TcPRACB proteins, respectively;
represents an alternative TcPRACA putative initiation
codon. Amino acid differences are indicated above and
below the vertical lines, and their positions in
the sequence are shown in parentheses. SP, signal
peptide; the N-terminal domain of TcPRACA extends from
positions 1 to 69. SPCGT, conserved active sites of
TcPRACA and TcPRACB proline racemases; N terminus
and C terminus are indicated for both proteins. C,
hydrophobicity profile of TcPRACA. Dotted line
depicts the cleavage site as predicted by Von Heijne's method (amino
acids 31-32). D, ethidium bromide-stained gel of
chromosomal bands of T. cruzi CL Brener clone after
separation by pulsed-field gel electrophoresis (lane 1) and
Southern blot hybridization with TcPRAC probe (lane
2). The sizes (Mb) of chromosomal bands are indicated,
as are the region chromosome numbers (in roman
numerals).
|
|
To verify whether the TcPRACB gene could encode a functional
proline racemase, we expressed both T. cruzi paralogs in
E. coli to produce C-terminal His6-tagged
recombinant proteins. After purification by affinity chromatography on
nickel-nitrilotriacetic acid-agarose column, recombinant proteins were
separated by SDS-gel electrophoresis revealing single bands with the
expected sizes of 45.8 and 40.1 kDa for the rTcPRACA and
rTcPRACB proteins, respectively (Fig.
2A). To determine whether
rTcPRACB displays proline racemase enzymatic activity,
biochemical assays were employed to measure the shift in optical
rotation of L- and D-proline substrates, as
described (13). As can be seen in Fig. 2B,
rTcPRACB racemizes both L- and
D-proline but not L-hydroxy-proline, like
rTcPRACA. In a similar manner, rTcPRACB is a
co-factor-independent proline racemase as described for CsPR (11) and
rTcPRACA (13) proline racemases. The rate of conversion of
L- into D-proline was measured at various pH
values using both recombinant enzymes. As illustrated in Fig.
2C, rTcPRACA activity clearly shows a pH
dependence with an optimal activity from pH 5.5 to 7.0. In contrast,
the optimum activity of rTcPRACB can be observed in a large
pH spectrum varying from pH 4.5 to 8.5. These results revealed that
translation of the open reading frame of both TcPRAC genes
copies result in functional proline racemase isoforms. As described
previously (13), Western blot analysis of non-infective epimastigote
parasite extracts using antibodies raised against the
45-kDa secreted proline racemase had previously revealed a 39-kDa
protein mostly in the soluble cellular fraction, only weakly in the
cellular insoluble fraction, and absent from culture medium. To
demonstrate that the intracellular 39-kDa isoform of the protein was
equally functional in vivo, soluble cellular extracts were
obtained from 5 × 108 epimastigote, non-infective
parasites, and the levels of 39-kDa soluble protein were quantified by
Western blot comparatively to known amounts of rTcPRACB
enzyme. As can be observed in Fig. 2D, the intracellular
isoform of the protein is indeed functional in vivo, because
proline racemase enzymatic activity was displayed, and levels of
racemization were dependent on protein concentration.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Biochemical characterization of T. cruzi proline racemase isoforms and substrate
specificities. A, SDS-PAGE analysis of purified
rTcPRACA (lane 1) and rTcPRACB
(lane 2) recombinant proteins. An 8% polyacrylamide gel was
stained with Coomassie Blue. Right margin, molecular
masses. B, percent of racemization of
L-proline, D-proline, L-hydroxy
(OH)-proline, and D-hydroxy (OH)-proline substrates by
rTcPRACB (open bar) as compared with
rTcPRACA (closed bar). Racemase activity was
determined with 0.25 µM of each isoform of proline
racemase and 40 mM substrate in sodium acetate buffer, pH
6.0. C, percent of racemization as a function of pH.
Racemase assays were performed in buffer containing 0.2 M
Tris-HCl (squares), sodium acetate (triangles),
and potassium phosphate (circles), 40 mM
L-proline and 0.25 µM of purified
rTcPRACA (closed symbols), and
rTcPRACB (open symbols). After 30 min at
37 °C, the reaction was stopped by heat inactivation and freezing.
D, 39-kDa intracellular isoform was isolated from
soluble (Ese) extracts of non-infective epimastigote forms
of the parasite. Western blots of serial dilutions of the soluble
suspension were compared with known amounts of rTcPRACB
protein and used for protein quantitation using Quantity One®
software. Racemase assays were performed in sodium acetate buffer, pH
6, using 40 mM L-proline and the equivalent
depicted amounts of 39 kDa (ng) contained in Ese extract.
|
|
Functional Analysis and Kinetic Properties of Recombinant T. cruzi
Proline Racemases--
Because the TcPRAC gene copies
encode for secreted and non-secreted isoforms of proline racemase with
distinct pH requirements for activity, we investigated whether other
biochemical properties differ between rTcPRACA and
rTcPRACB proteins. Such differences might reflect the
cellular localization of the protein during parasite differentiation
and survival in the host. Both rTcPRACA and
rTcPRACB enzyme activities are maximal at 37 °C and can
be abolished by heating for 5 min at 80 °C. However, the stability of the two recombinant enzymes differs considerably when analyzed under
different storage conditions. Thus, as shown in Table
I, purified rTcPRACB is highly
stable, because its activity is maintained for at least 10 days at room
temperature in 0.5 M imidazole buffer, pH 8.0, as compared
with rTcPRACA, which loses 84% of its activity under such
conditions. In contrast, most of the enzymatic activity of
rTcPRACA is maintained at 4 °C (65%), compared with that
of rTcPRACB (34%). Both enzymes can be preserved in 50%
glycerol at 20 °C or diluted in sodium acetate buffer at pH 6.0, but under these storage conditions rTcPRACA activity is
impaired. However, best preservation of both recombinant proline
racemases was undoubtedly obtained when proteins were kept at
20 °C as ammonium sulfate precipitates.
View this table:
[in this window]
[in a new window]
|
Table I
Stability of recombinant TcPRACA and TcPRACB proline racemases under
different storage conditions
After purification on nickel-nitrilotriacetic acid-agarose column,
recombinant proteins were kept for 10 days in nickel column buffer (20 mM Tris/500 mM NaCl/500 mM
imidazol, pH 8.0) at room temperature (RT) or at +4 °C or diluted
either in 50% glycerol and maintained at 20 °C (Gly/ 20 °C)
or in optimum pH buffer (NaOAc, pH 6.0) at 4 °C. Recombinant enzymes
were precipitated in (NH4)2SO4 and kept in
solution at 4 °C or pellet dried at 20 °C. Racemase assays were
performed for 30 min at 37 °C. Percent of preservation was
determined polarimetrically using 0.25 µM of either
purified rTcPRACA or rTcPRACB enzymes and 40 mM of L-proline, as compared with results obtained with
freshly purified proteins (CTRL). This results are representative of at
least two independent experiments.
|
|
Both recombinant enzymes exhibited Michaelis-Menten kinetics (Fig.
3A), and rTcPRACB
had a higher activity than rTcPRACA. Indeed, as can be
observed in Fig. 3B, analysis of L D conversion of serial dilutions of L-proline
catalyzed by a constant amount of each enzyme showed that
rTcPRACB enzyme (Km of 75 mM
and Vmax of 2 × 10 4
mol·s 1) has a higher velocity as compared with
rTcPRACA (Km of 29 mM and
Vmax of 5.3 × 10 5
mol·s 1). To determine the Ki values
for PAC, the specific and competitive inhibitor of CsPR (16),
assays were performed with both recombinant proteins. These assays
revealed that PAC is comparably effective as inhibitor of
rTcPRACA (Fig. 3C) and rTcPRACB (not shown), and Ki values obtained were 5.7 and 3.6 µM, respectively. The difference in Ki
values reflects almost perfectly the difference in
Km values reported for both enzymes, which are
similar to that of the native protein (not shown). These Ki values indicate that the affinity of PAC
inhibitor is higher for rTcPRACA and rTcPRACB
than for CsPR (Ki of 18 µM).

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 3.
Kinetic parameters of L-proline
racemization catalyzed by rTcPRACA and
rTcPRACB proline racemase isoforms. The progress
of racemization reaction was monitored polarimetrically, as described
previously (13). A, the determination of the linear part of
the curve was performed at 37 °C in medium containing 0.2 M sodium acetate, pH 6.0, 0.25 µM purified
enzyme, and 40 mM L-proline.
rTcPRACA reactions are represented by black
squares, and rTcPRACB reactions are represented by
white squares. B, initial rate of racemase
activity was assayed at 37 °C in medium containing 0.2 M
sodium acetate, pH 6.0, 0.125 µM rTcPRACA
(solid squares), or rTcPRACB (open
squares) purified enzymes and different concentrations of
L-proline. Lineweaver-Burk double reciprocal plots were
used to determine values for Km and Vmax
where 1/V is plotted in function of 1/[S], and the slope of the curve
represents Km/Vmax. Values
obtained were confirmed by using the Kaleïdagraph® program and
Michaelis-Menten equation. The values are representative of six
experiments with different enzyme preparations. C, double
reciprocal plot kinetics of 0.125 µM rTcPRACA
proline racemase isoform in the presence (open) or absence
(closed) of 6.7 µM PAC competitive inhibitor
in function of L-proline concentration. For comparison,
Km reported for the proline racemase of C. sticklandii was 2.3 mM; kinetic assays using the
native protein obtained from a soluble epimastigote fraction revealed a
Km of 10.7 mM and a
Ki of 1.15 µM.
|
|
Requirement of a Dimeric Structure for Proline Racemase
Activity--
When rTcPRACA was submitted to size exclusion
chromatography on a Superdex 75 column at pH 6.0, two peaks of protein
were eluted around 80 kDa (B2 fraction) and 43 kDa (B4 fraction),
respectively, presumably corresponding to dimeric and monomeric forms
of the enzyme (Fig. 4). Western blot
analysis of whole T. cruzi epimastigote extracts using
non-denaturing PAGE had previously indicated a molecular mass of 80 kDa
for the native protein (not shown), whereas a 45-kDa band was obtained
by SDS-PAGE (13). To eliminate cross-contamination, B1 and B5
fractions, eluted at the start and at the end of the predicted dimer
(B2) or monomer (B4) peaks, respectively, were reloaded onto the
column, and the profiles obtained (see Fig. 4, insets)
confirmed the purity of the fractions. Enzyme activity resides in the
80-kDa peak but not in the 43-kDa peak (Table
II). These results corroborated that two
subunits of the protein are necessary for racemase activity. At neutral
pH (7.4 or above), the rTcPRACA gives rise to high molecular
weight aggregates that are not observed with rTcPRACB,
consistently with its broader optima pH spectrum (not shown).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Size exclusion chromatography of
rTcPRACA protein using a Superdex 75 column.
Fractions were eluted by high pressure liquid chromatography at pH 6.0;
B2 and B4 peaks correspond to rTcPRACA
dimer and monomer species, respectively. B1 and
B5 eluted fractions were reloaded onto the column
(bold; see insets) using the same conditions and
compared with previous elution profile (not bold).
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Racemase activity of recombinant TcPRACA fractions after size exclusion
chromatography
After elution from Superdex 75 column, 20 µl of each peak (A15 to B7;
see Fig. 4) corresponding to 1 µg of protein were incubated for
1 h at 37 °C with 40 mM L-proline in 0.2 M NaOAc, pH 6.0. Optical rotation was measured, and % of
racemization was determined as described under "Experimental
Procedures."
|
|
Abrogation of Proline Racemase Activity by Mutation of
Cys330 of the Catalytic Site--
C.
sticklandii proline racemase is described as a homodimeric enzyme
with subunits of 38 kDa and a single proline binding site for every two
subunits, where two cysteines at position 256 might play a crucial role
in catalysis by the transfer of protons from and to the bound substrate
(12). We have shown previously (16) that mitogenic properties of the
T. cruzi proline racemase are dependent on the integrity of
the enzyme active site, as inhibition of B-cell proliferation is
obtained by substrate competition and specific use of analogues (PAC)
resembling the structure assumed by the substrate proline in its
transition state. To verify the potential role of the cysteine residues
at the active site of the T. cruzi proline racemase, we
replaced Cys330 by a serine residue through site-specific
mutation of TcPRACA. The choice of serine as the
substituting amino acid was made to avoid further major disturbances on
three-dimensional structure of the protein (see strategy in Fig.
5 and "Experimental Procedures"). After confirmation of the single codon mutation through sequencing of
the construct (not shown), the
C330SrTcPRACA mutant proline racemase was
expressed in E. coli and purified in the same manner as
wild-type rTcPRACA. We then used C330SrTcPRACA in racemization assays to
verify the effects of the mutation on the enzymatic activity of the
protein. As can be observed in Table III,
a total loss of proline racemase activity is observed as compared with
the wild-type enzyme, establishing that proton transfer during proline
racemization is specifically dependent on the presence of the cysteine
residue in the active site.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Site-directed mutagenesis of
TcPRACA proline racemase. Schematic
representation of the active site mutagenesis of proline racemase of
TcPRACA gene.
|
|
View this table:
[in this window]
[in a new window]
|
Table III
Loss of racemase enzymatic activity in the site-directed
C330STcPRACA
After purification, 5 µg of rTcPRACA or
C330SrTcPRACA were incubated at 37 °C with 40 mM L-proline in NaOAc buffer, pH 6.0. Optical rotation was
measured at different times and % of racemization was determined as
described under "Experimental Procedures."
|
|
Proline Racemase Protein Signatures and Putative Proline Racemases
in Sequence Databases--
The conservation of critical residues
between parasite and bacterial proline racemases prompted us to search
for similarities between TcPRAC and other protein sequences
in SWISS-PROT and TrEMBL databases. Twenty-one protein sequences
yielded significant homologies, from 11 organisms, such as several
proteobacteria of the -subdivision (Agrobacterium,
Brucella, Rhizobium) and -subdivision
(Xanthomonas and Pseudomonas), as well as of the
fermicutes (Streptomyces and Clostridium). Within
the eukaryota, besides in T. cruzi, homologous genes were
detected in the human and mouse genomes, where predicted proteins show
overall similarities with proline racemase. Except for
C. sticklandii and Xantomonas
campestri, each other organism encodes two paralogs, and
Agrobacterium tumefaciens contains three genes. The multiple
alignment also allowed for the definition of three signatures of
proline racemase, which are described here in PROSITE format. As can be
seen in Table IV, when using a minimal motif of proline racemase protein (M I),
[IVL][GD]XHXXG[ENM]XX[RD]X[VI]XXG, located immediately after the start codon at position 79, we obtained nine hits. A second motif (M II), consisting of
[NSM][VA][EP][AS][FY]X- (13,
14)[GK]X[IVL]XXD[IV][AS][YWF]GGX[FWY],
starting at position 218, gave 14 hits; however, the first or the
second half of this motif is not sufficiently stringent to be
restrictive for putative proline racemases but gives hits for different
protein families. A third motif (M III), from positions 326 to 339, namely DRSPXGX[GA]XXAXXA, was considered as a minimal pattern. Note that in position 330, the
cysteine of the active site was replaced by an X. As shown in Table IV, this minimal pattern yields all 21 hits. Curiously, both
genes in human, as well as in mouse, encode threonine instead of
cysteine at the X position in motif III, whereas in
Brucella, Rhizobium, and
Agrobacterium species, each encode one protein with C and
one with T in this position. We cannot hypothesize the implications of
this substitution for the functionality of these putative proteins. If
the residue at position 330 is maintained as a cysteine in motif III, a
reduced number of 12 hits from nine organisms is thus obtained, which
can probably be considered as true proline racemases. The alignment of
the 21 protein sequences and derived cladogram are shown
in Fig. 6 and Fig.
7, respectively, and the three
boxes depicted correspond to motifs I, II, and III described
above. We thus propose DRSPCGXGXXAXXA
as the minimal signature for proline racemases. BLAST searches against
unfinished genomes yielded, at present, an additional 13 predicted
protein sequences from 9 organisms, with high similarity to proline
racemases, all containing motif III. Organisms are Clostridium
difficile, Clostridium botulinum, Bacillus
anthracis, Brucella suis, Pseudomonas putida, Rhodobacter sphaeroides, Burkholderia
pseudomallei, Burkholderia mallei, and the fungus
Aspergillus fumigatus. These results indicate that proline
racemases might be quite widespread.
View this table:
[in this window]
[in a new window]
|
Table IV
SWISS-PROT and TrEMBL databases screening using PROSITE motifs
SWISS-PROT and TrEMBL databases were screened using motifs I to III (M
I, M II and M III). M I corresponds to
[IVL][GD]XHXXG[ENM]XX[RD]X[VI]XXG,
M II to of [NSM][VA][EP][AS][FY]X(13,
14)[GK]X[IVL]XXD[IV][AS][YWF]GGX[FWY],
M III to DRSPXGXGXXAXXA,
and M III* to DRSPCGXGXXAXXA. Access.
nb, SWISS-PROT accession number of the sequence; Seq. sequence number
according to Fig. 6; + and , presence or absence, respectively, of
hit using the corresponding motif.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 6.
Sequence alignments of proteins (Clustal X)
obtained by screening SWISS-PROT and TrEMBL databases using motifs I,
II, and III. Amino acids involved in MI, MII, and MIII are shaded
in dark gray. The 13-14 unspecific amino acids involved in
M II are shaded in light gray. SWISS-PROT accession
numbers of the sequences are in Table IV.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
Cladogram of protein sequences obtained by
T-coffee alignment radial tree. See Table IV for SWISS-PROT
protein accession numbers.
|
|
 |
DISCUSSION |
Proline racemase, an enzyme previously only described in
protobacterium C. sticklandii (11), was shown to be encoded
also by the eukaryote T. cruzi, a highly pathogenic
protozoan parasite (13). The TcPRAC (T. cruzi proline racemase), formerly called TcPA45,
is an efficient mitogen for host B cells and is secreted by the
metacyclic forms of the parasite upon infection, contributing to its
immune evasion and persistence through nonspecific polyclonal lymphocyte activation (13). Our previous results (13) suggested that
TcPRAC is encoded by two paralogous genes per haploid
genome. Protein localization studies have also indicated that T. cruzi can differentially express intracellular and secreted
versions of TcPRAC during cell cycle and differentiation, as
the protein is found in the cytoplasm of non-infective replicative
(epimastigote) forms of the parasite, and bound to the membrane or
secreted in the infective, non-replicative (metacyclic trypomastigote)
parasites (13). Here we have characterized the two TcPRAC
paralogs and demonstrated that both TcPRACA and
TcPRACB give rise to functional isoforms of
co-factor-independent proline racemases, which display different
biochemical properties that may well have important implications in the
efficiency of the respective enzymatic activities. As suggested
previously (11, 17, 18) by biochemical and theoretical studies for the
bacterial proline racemase, our studies reveal that TcPRAC
activities rely on two monomeric enzyme subunits that perform
interconversion of L- and/or D-proline
enantiomers by a two-base mechanism reaction in which the enzyme
removes an -hydrogen from the substrate and donates a proton to the
opposite side of the -carbon. It has been predicted that each
subunit of the homodimer furnishes one of the sulfhydryl groups (18). In the present work we showed that TcPRAC enzymatic
activities are bona fide dependent on the Cys330
residue of the active site, as site-specific C330S mutation totally abrogates L- and D-proline racemization, in
agreement with our previous demonstration (13) that TcPRAC
enzymatic activity is abolished through alkylation with iodoacetate or
iodoacetamine, similarly to the Clostridium proline
racemase, where carboxymethylation was shown to occur specifically with
the two cysteines of the reactive site leading to enzyme inactivation
(12). Although gene sequence analysis predicted that by a mechanism of
alternative splicing TcPRACA could generate both
intracellular and secreted versions of parasite proline racemase, our
present studies demonstrate that TcPRACB gene sequence
per se codes for a protein lacking the amino acids involved
in peptide signal formation and an extra N-terminal domain present in
TcPRACA protein, resembling more closely the CsPR. Thus,
TcPRACB can only generate an intracellular version of
TcPRAC proline racemase.
Interestingly, the presence of two homologous copies of
TcPRAC genes in the T. cruzi genome, coding for
two similar but with distinct specific biochemical properties, could
reflect an evolutionary mechanism of gene duplication and a parasite
strategy to ensure a better environmental flexibility. This assumption
is comforted by the potential of TcPRACA gene to generate
two related protein isoforms by alternative splicing, a mechanism that
is particularly adept for cells that must respond rapidly to
environmental stimuli. Primarily, trans-splicing appears
indeed to be an ancient process that may constitute a selective
advantage for split genes in higher organisms (19), and alternative
trans-splicing was only proven to occur in T. cruzi recently (20). As an alternative for promoter selection,
the regulated production of intracellular and/or secreted isoforms of
proline racemase in T. cruzi by alternative
trans-splicing of TcPRACA gene would allow the
stringent conservation of a constant protein domain and/or the
possibility of acquisition of an additional secretory region domain. As
a matter of fact, our recent investigations using RT-PCR based strategy
and a common 3' probe to TcPRACA and TcPRACB
sequences combined to a 5' spliced leader oligonucleotide followed by
cloning and sequencing of the resulting fragments have indeed proved
that an intracellular version of TcPRAC may also originate
from the TcPRACA gene, corroborating this
hypothesis.2,3
Gene duplication is a relatively common
event in T. cruzi that adds complexity to parasite genomic
studies. Moreover, TcPRAC chromosomal mapping revealed two
chromosomal bands that possess more than three chromosomes each and
that may indicate that proline racemase genes are mapped in
size-polymorphic homologous chromosomes, an important finding for
proline racemase gene family characterization. Preliminary results in
this laboratory have, for instance, revealed that T. cruzi
DM28c type I strain maps proline racemase genes to the same chromoblot
regions identified with T. cruzi CL type II strain used in
the present work. Other isolates of the parasites are presently under
investigation (data not shown).
It is well known that proline constitutes an important source of energy
for several organisms, such as several hemoflagellates (21-23), and
for flight muscles in insects (24). Furthermore, a proline oxidase
system was suggested in trypanosomes (25), and the studies reporting
the abundance of proline in triatominae guts (26) have implicated
proline in metabolic pathways of T. cruzi parasites, as well
as in its differentiation in the digestive tract of the insect vector
(27). Thus, it is well accepted that T. cruzi can use
L-proline as a principal source of carbon (25). Moreover,
our preliminary results using parasites cultured in defined
media indicate that both epimastigotes, found in the vector, and
infective metacyclic trypomastigote forms can efficiently metabolize
L- or D-proline as the sole source of carbon
(not shown). Although certain reports indicate that biosynthesis of
proline occurs in trypanosomes, i.e. via reduction of
glutamate carbon chains or transamination reactions, our results reveal
that an additional and direct physiological regulation of proline might exist in the parasite to control amino acid oxidation and its subsequent degradation or yet to allow proline utilization. In fact, a
recent report (28) showed two active proline transporter systems in
T. cruzi. We suggest that T. cruzi proline
racemase may possibly play a consequential role in the regulation of
intracellular proline metabolic pathways, or else it could participate
in mechanisms of post-translational addition of D-amino
acid to polypeptide chains. On one hand, these hypotheses would allow
for an energy gain and, on the other hand, would permit the parasite to
evade host responses. In this respect, it was reported that a single D-amino acid addition in the N terminus of a protein is
sufficient to confer general resistance to lytic reactions involving
host proteolytic enzymes (29). The expression of proteins containing D-amino acids in the parasite membrane would benefit the
parasite inside host cell lysosomes, in addition to the contribution to the initiation of polyclonal activation, as described previously (30,
31) for polymers composed of D-enantiomers. Although D-amino acid inclusion in T. cruzi proteins
would benefit the parasite, this hypothesis remains to be proven, and
direct evidences are technically difficult to obtain.
It is worth noting that metacyclogenesis of epimastigotes into
infective metacyclic forms involves parasite morphologic changes that
include the migration of the kinetoplast, a structure that is
physically linked to the parasite flagellum, and many other significant
metabolic alterations that combine to confer infectivity/virulence to
the parasite (13, 32). Proline racemase was shown to be preferentially
localized in the flagellar pocket of infective parasite forms after
metacyclogenesis (13), as are many other known proteins secreted and
involved in early infection (33). It is also conceivable that parasite
proline racemase may function as an early mediator for T. cruzi differentiation through intracellular modification of
internalized environmental free proline, as suggested above and already
observed in some bacterial systems. As an illustration, exogenous
alanine has been described as playing an important role in bacterial
transcriptional regulation by controlling an operon formed by genes
coding for alanine racemase and a smaller subunit of bacterial
dehydrogenase (34). In bacteria, membrane alanine receptors are
responsible for alanine and proline entry into the bacterial cell (35).
We can then hypothesize that the availability of proline in the insect
gut milieu associated to a mechanism of environmental sensing by
specific receptors in the parasite membrane would stand for parasite
proline uptake and its further intracellular racemization. Proline
racemase would then play a fundamental role in the regulation of
parasite growth and differentiation by its participation in both
metabolic energetic pathways and the expression of proteins containing
D-proline, as described above, consequently conferring
parasite infectivity and its ability to escape host-specific responses.
Thus far, and contrasting to the intracellular isoform of
TcPRAC found in epimastigote forms of T. cruzi,
the ability of metacyclic and bloodstream forms of the parasite to
express and secrete proline racemase may have further implications in
host/parasite interaction. In fact, the parasite-secreted isoform of
proline racemase participates actively in the induction of nonspecific
polyclonal B-cell responses upon host infection (13) and favors
parasite evasion, thus ensuring its persistence in the host. As
described for other mitogens and parasite antigens (36-38), and in
addition to its mitogenic property, TcPRAC could also be
involved in modifications of host cell targets enabling better parasite
attachment to host cell membranes, in turn assuring improved
infectivity. Because several reports associate accumulation of
L-proline with muscular dysfunction (39) and inhibition of
muscle contraction (40), the release of proline racemase by
intracellular parasites could alternatively contribute to the
maintenance of infection through regulation of L-proline concentration inside host cells, as proline was described as essential for the integrity of muscular cell targets. Therefore, we have demonstrated recently that transgenic parasites hyperexpressing TcPRACA or TcPRACB genes, but not functional
knock-outs, are five to ten times more infective to host target cells,
pointing to a critical role of proline racemases in the ongoing of the
infectious process.2,3 Likewise, previous reports (41)
demonstrated that genetic inactivation of Lysteria
monocytogenes alanine racemase and D-amino acid
oxidase genes abolishes bacterial pathogenicity, because the presence of D-alanine is required for the synthesis of the
mucopeptide component of the cell wall that protects virtually all
bacteria from the external milieu.
Present analysis using identified critical conserved residues in
TcPRAC and C. sticklandii proline racemase genes
and the screening of SWISS-PROT and TrEMBL databases led us to define of a minimal signature for proline racemases,
DRSPXGX[GA]XXAXXA, and to
confirm the presence of putative proteins in at least ten distinct
organisms. Screening of unfinished genome sequences showed highly
homologous proline racemase candidate genes in an additional 9 organisms, among which are the fungus A. fumigatus and the
bacteria B. anthracis and C. botulinum. This
is of particular interest, because racemases, but not proline
racemases, are widespread in bacteria and only recently described in
more complex organisms such as T. cruzi (42, 43). These
findings may possibly reflect cell adaptative responses to
extracellular stimuli and uncover more general mechanisms for the
regulation of gene expression by D-amino acids in
eukaryotes. Our finding of similar genes in human and mouse genome
databases when we used less stringent signatures for proline racemase
is striking. However, the absence of the crucial amino acid cysteine in
the putative active site of those predicted proteins suggests a
different functionality than that of a proline racemase.
Finally, we described here that TcPRAC isoforms are highly
stable and have the capacity to perform their activities across a large
spectrum of pH. In addition, the affinity of pyrrol-carboxylic acid, a
specific inhibitor of proline racemase, is higher for TcPRAC
enzymes than for CsPR. Because proline racemase is a protein involved
in the mechanisms leading to T. cruzi immune
evasion, our work should stimulate further studies on biochemical and
molecular characterization of putative proline racemases in other
microorganisms and draw attention to their importance as potential
targets for drug development.
 |
ACKNOWLEDGEMENTS |
We thank A. Waters for critical discussions,
A. Cosson for help with the recombinant proteins, A. Berneman
for advice, L. Mulard for access to the polarimeter facilities, and F. Lacoste for constant support of N. C.
 |
FOOTNOTES |
*
This work was supported in part by Institut Pasteur and CNRS
URA 1960.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY 1409447.
§
Contributed equally to this work.
¶
Fellow of the Pasteur Institute.
§§
To whom correspondence should be addressed. Tel./Fax:
33-1-45-68-86-15; E-mail: pmm@pasteur.fr.
Published, JBC Papers in Press, February 11, 2003, DOI 10.1074/jbc.M210830200
2
N. Chamond, N. Coatnoan, J. C. Barale, A. Cosson, A. Berneman, W. Degrave, and P. Minoprio, manuscript in preparation.
3
The proline racemase/B-cell mitogen of T. cruzi is a virulence factor whose mRNA is regulated
differentially through development by alternative splicing.
 |
ABBREVIATIONS |
The abbreviations used are:
PAC, pyrrole-2-carboxylic acid;
CsPR, C. sticklandii proline
racemase.
 |
REFERENCES |
| 1.
|
Lamzin, V. S.,
Dauter, Z.,
and Wilson, K. S.
(1995)
Curr. Opin. Struct. Biol.
5,
830-836[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Kleinkauf, H.,
and von Dohren, H.
(1987)
Annu. Rev. Microbiol.
41,
259-289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Fisher, G. H.
(1998)
Exper. Suppl.
85,
109-118
|
| 4.
|
Nagata, Y.,
Fujiwara, T.,
Kawaguchi-Nagata, K.,
Fukumori, Y.,
and Yamanaka, T.
(1998)
Biochim. Biophys. Acta
1379,
76-82[Medline]
[Order article via Infotrieve]
|
| 5.
|
Nagata, Y.,
Tanaka, K.,
Iida, T.,
Kera, Y.,
Yamada, R.,
Nakajima, Y.,
Fujiwara, T.,
Fukumori, Y.,
Yamanaka, T.,
Koga, Y.,
Tsuji, S.,
and Kawaguchi- Nagata, K.
(1999)
Biochim. Biophys. Acta
1435,
160-166[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Oguri, S.,
Kumazaki, M.,
Kitou, R.,
Nonoyama, H.,
and Tooda, N.
(1999)
Biochim. Biophys. Acta
1472,
107-114[Medline]
[Order article via Infotrieve]
|
| 7.
|
Neidle, A.,
and Dunlop, D. S.
(1990)
Life Sci.
46,
1512-1522
|
| 8.
|
Schell, M. J.,
Molliver, M. E.,
and Snyder, S. H.
(1995)
Proc. Nat. Acad. Sci.
92,
3948-3952[Abstract/Free Full Text]
|
| 9.
|
Wolosker, H.,
Blackshaw, S.,
and Snyder, S. H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13409-13414[Abstract/Free Full Text]
|
| 10.
|
Nagata, Y.,
Homma, H.,
Matsumoto, M.,
and Imai, K.
(1999)
FEBS
454,
317-320[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Cardinale, G. J.,
and Abeles, R. H.
(1968)
Biochemistry
7,
3970-3978[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Rudnick, G.,
and Abeles, R. H.
(1975)
Biochemistry
14,
4515-4522[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Reina-San-Martin, B.,
Degrave, W.,
Rougeot, C.,
Cosson, A.,
Chamond, N.,
Cordeiro-da-Silva, A.,
Arala-Chaves, M.,
and Minoprio, P.
(2000)
Nat. Med.
6,
890-897[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Cano, M. I.,
Gruber, A.,
Vazquez, M.,
Cortés, A.,
Levin, M. J.,
González, A.,
Degrave, W.,
Rondinelli, E.,
Zingales, B.,
Ramirez, J. L.,
Alonso, C.,
Requena, J. M.,
and Silveira, J. F. D.
(1995)
Mol. Biochem. Parasitol.
71,
273-278[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Higuchi, R.,
Krummel, B.,
and Saiki, K. K.
(1988)
Nucleic Acids Res.
16,
7351-7367[Abstract/Free Full Text]
|
| 16.
|
Keenan, M. V.,
and Alworth, W. L.
(1974)
Biochem. Biophys. Res. Commun.
57,
500-504[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Fisher, L. M.,
Albery, W. J.,
and Knowles, J. R.
(1986)
Biochemistry
25,
2529-2537[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Albery, W. J.,
and Knowled, J. R.
(1986)
Biochemistry
25,
2572-2577[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Breitbart, R. E.,
Andreadis, A.,
and Nadal-Ginard, B.
(1987)
Annu. Rev. Biochem.
56,
467-495[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Manning-Cela, R.,
Gonzalez, A.,
and Swindle, J.
(2002)
Infect. Immun.
70,
4726-4728[Abstract/Free Full Text]
|
| 21.
|
Krassner, S. M.,
and Flory, B.
(1972)
J. Protozool.
19,
917-920
|
| 22.
|
Bowman, I. B. R.,
Srivastava, H. K.,
and Flynn, I. W.
(1972)
in
Comparative Biochemistry of Parasites
(Van den Bossche, H., ed)
, Academic Press, New York
|
| 23.
|
Evans, D. A.,
and Brown, R. C.
(1972)
J. Protozool.
19,
686-690[Medline]
[Order article via Infotrieve]
|
| 24.
|
Auerswald, L.,
Schneider, P.,
and Gade, G.
(1998)
J. Exp. Biol.
201,
2333-2342[Abstract]
|
| 25.
|
Sylvester, D.,
and Krassner, S. M.
(1976)
Comp. Biochem. Physiol.
55,
443-447[CrossRef]
|
| 26.
|
de Isola, E. L.,
Lammel, E. M.,
Katzin, V. J.,
and Gonzalez Cappa, S. M.
(1981)
J. Parasitol.
67,
53-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Contreras, V. T.,
Salles, J. M.,
Thomas, N.,
Morel, C. M.,
and Goldenberg, S.
(1985)
Mol. Biochem. Parasitol.
16,
315-327[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Silber, A. M.,
Tonelli, R. R.,
Martinelli, M.,
Colli, W.,
and Alves, M. J.
(2002)
J. Eukaryot. Microbiol.
49,
441-446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Janeway, C. A.,
and Humphrey, J. H.
(1970)
Folia Biol. (Prague)
16,
156-172
|
| 30.
|
Mozes, E.,
Kohn, L. D.,
Hakim, F.,
and Singer, D. S.
(1993)
Science
261,
91-92[Abstract/Free Full Text]
|
| 31.
|
Sela, M.,
and Zisman, E.
(1997)
FASEB J.
11,
449-456[Abstract]
|
| 32.
|
Contreras, V. T.,
Morel, C. M.,
and Goldenberg, S.
(1985)
Mol. Biochem. Parasitol.
14,
83-96[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Souto-Padron, T.,
Reyes, M. B.,
Leguizamon, S.,
Campetella, O. E.,
Frash, A. C.,
and de Souza, W.
(1989)
Eur. J. Cell Biol.
50,
272-278[Medline]
[Order article via Infotrieve]
|
| 34.
|
Janes, B. K.,
and Bender, R. A.
(1998)
J. Bacteriol.
180,
563-570[Abstract/Free Full Text]
|
| 35.
|
de Jong, M. H.,
van der Drift, C.,
and Vogels, G. D.
(1975)
J. Bacteriol.
123,
824-827[Abstract/Free Full Text]
|
| 36.
|
Shakibaei, M.,
and Frevert, U.
(1996)
J. Exp. Med.
184,
1699-1711[Abstract/Free Full Text]
|
| 37.
|
Burleigh, B. A.,
and Andrews, N. W.
(1998)
Curr. Opin. Microbiol.
1,
461-465[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Gao, W.,
Wortis, H. H.,
and Pereira, M. A.
(2002)
Int. Immunol.
14,
299-308[Abstract/Free Full Text]
|
| 39.
|
Martin, D.,
Ault, B.,
and Nadler, J. V.
(1992)
Eur. J. Pharmacol.
219,
59-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Van Harreveld, A.
(1980)
J. Neurobiol.
11,
519-529[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Thompson, R. J.,
Bouwer, H. G.,
Portnoy, D. A.,
and Frankel, F. R.
(1998)
Infect. Immunol.
66,
3552-3561[Abstract/Free Full Text]
|
| 42.
|
Wolosker, H.,
Sheth, K. N.,
Takahashi, M.,
Mothet, J. P.,
Brady, R. O., Jr.,
Ferris, C. D.,
and Snyder, S. H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
721-725[Abstract/Free Full Text]
|
| 43.
|
Watanabe, T.,
Shibata, K.,
Kera, Y.,
and Yamada, R.
(1998)
Amino Acids
14,
353-360[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Spera, J. E. Ugalde, J. Mucci, D. J. Comerci, and R. A. Ugalde
A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection
PNAS,
October 31, 2006;
103(44):
16514 - 16519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Buschiazzo, M. Goytia, F. Schaeffer, W. Degrave, W. Shepard, C. Grégoire, N. Chamond, A. Cosson, A. Berneman, N. Coatnoan, et al.
Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma cruzi proline racemase
PNAS,
February 7, 2006;
103(6):
1705 - 1710.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|